A case series of peripheral neuropathy in patients with Parkinson's disease

Annals of Neurology

Volumn 68, Issue 6, 2010, Pages 973-975

  Gondim, Francisco De Assis Aquino ^a,b   De Oliveira, Gisele R ^a,b   Peixoto Jr , Arnaldo Aires ^a   Horta, Wagner G ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; BENSERAZIDE PLUS LEVODOPA; BENZATROPINE; CYANOCOBALAMIN; ENTACAPONE; FOLIC ACID; HOMOCYSTEINE; IMMUNOGLOBULIN; PRAMIPEXOLE; ROPINIROLE;

AGED; CASE STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; DEMYELINATION; FEMALE; HUMAN; IDIOPATHIC DISEASE; LETTER; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; PARKINSON DISEASE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEVODOPA; MALE; PARKINSON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; RETROSPECTIVE STUDIES; VITAMIN B COMPLEX;

EID: 78650906325     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22258     Document Type: Letter

References (5)

1. Toth C, Breithaupt K, Shaohua G, et al. Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease. Ann Neurol 2010; 67: 28-36.
2. Gondim FA, Peixoto Jr AA, Oliveira GR, et al. A case series of peripheral neuropathy (PN) and Parkinson's disease. Mov Disord 2009; 24 (suppl 1): S320.
3. Toth C, Sutton Brown M, Furtado S, et al. Neuropathy as a potential complication of levodopa use in Parkinson's disease. Mov Disord 2008; 23: 1850-1859.
4. Abbruzzese G, Pigullo S, Schenone A, Bellone E, et al. Does Parkin play a role in the peripheral nervous system? A family report. Mov Disord 2004; 19: 978-981.
5. Ohsawa Y, Kurokawa K, Sonoo M, Yamada H, et al. Reduced amplitude of the sural nerve action potential in PARK2 patients. Neurology 2005; 65: 459-462.